
Lupin Limited has informed the Exchange regarding a press release dated May 10, 2021, titled "Lupin enters into Voluntary Licensing Agreement with Lilly to Expand Access for COVID-19 Treatment in India.".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated May 10, 2021, titled "Lupin enters into Voluntary Licensing Agreement with Lilly to Expand Access for COVID-19 Treatment in India.".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin